Armstrong, A. J., Antonarakis, E. S., Taplin, M.-E., Kelly, W. K., Beltran, H., Fizazi, K., … Scher, H. I. (2018). Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet. Ann Oncol, 29(1), 23–25. https://doi.org/10.1093/annonc/mdx648

Armstrong, A. J., E. S. Antonarakis, M. -. E. Taplin, W. K. Kelly, H. Beltran, K. Fizazi, W. L. Dahut, et al. “Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.” Ann Oncol 29, no. 1 (January 1, 2018): 23–25. https://doi.org/10.1093/annonc/mdx648.

Armstrong AJ, Antonarakis ES, Taplin M-E, Kelly WK, Beltran H, Fizazi K, et al. Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet. Ann Oncol. 2018 Jan 1;29(1):23–5.

Armstrong, A. J., et al. “Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.” Ann Oncol, vol. 29, no. 1, Jan. 2018, pp. 23–25. Pubmed, doi:10.1093/annonc/mdx648.

Armstrong AJ, Antonarakis ES, Taplin M-E, Kelly WK, Beltran H, Fizazi K, Dahut WL, Shore N, Slovin S, George D, Carducci MA, Corn P, Danila D, Dreicer R, Heath E, Rathkopf D, Liu G, Nanus D, Stein M, Smith MR, Sternberg C, Wilding G, Nelson PS, Halabi S, Kantoff P, Clarke NW, Evans CP, Heidenreich A, Mottet N, Gleave M, Morris MJ, Scher HI. Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet. Ann Oncol. 2018 Jan 1;29(1):23–25.